Unicancer Innov
NewsRoom News
Fr En

Research
area

Research holds a fundamental place at Unicancer, encompassing the fields of clinical research, translational research, and health data. Its methodical and organized approach aims to place innovation at the service of patients.

Governance
of Unicancer
Research

Clinical
Research

Health
Data
Research

Over 700 active clinical trials sponsored

Major player in oncology in France and internationally, Unicancer benefits from the strength of a dynamic, engaged, and pioneering network.

En cours de recrutement

Expert group : MED PERSO

  • Sein

SAFIR03 SCREENING/ARRIBA

A ctDNA screening program in patients with HR+, HER2 negative metastatic breast cancer for detection of high-risk relapse patients on any CDK4/6 inhibitor and a randomised phase II study comparing alpelisib combined with fulvestrant to ribociclib combined with fulvestrant, in patients with persistent targetable PIK3CA mutations

Principal investigator : Pr Fabrice André

Etude Phase II

Sponsor : UNICANCER

Unicancer Contact Marta JIMENEZ

En cours de recrutement

Expert group : MED PERSO

  • Vésicule biliaire

SAFIR ABC10

Molecular targeted maintenance therapy versus standard of care in advanced biliary cancer: an international, randomised, controlled, open-label, platform phase 3 trial

Principal investigator : Dr David MALKA

Etude Phase III

Sponsor : UNICANCER

Unicancer Contact MARTA JIMENEZ

En cours de recrutement

Expert group : SARCOME

  • Tissus mous

L-UTECIN

Interest of adjuvant chemotherapy in patients with CINSARC high-risk localized resected uterine leiomyosarcoma

Principal investigator : Pr Florence DUFFAUD

Etude Phase II

Sponsor : UNICANCER

Unicancer Contact Marta JIMENEZ

Consulter tous les essais cliniques

10 expert groups, including 6 accredited by INCa

Synonyms of Unicancer’s research excellence: 10 expert groups work daily to advance cancer research.

Unicancer
Research Groups

Organs and cross-functional teams
Transversal Groups